About Balboa Research
*Formerly California Institute of Renal Research
Balboa Research is a strategic Study Management Organization that collaborates early on cutting edge-therapeutics with Pharma and Device sponsors.
Our important role in executing clinical trials that Pioneer New Therapeutics is manifest through Pride in Our GCP Processes and having Passion for the Patients we serve.
History
- Over two decades of delivering quality GCP studies, including multiple Investigator Initiated Studies (IIS)
- 500+ studies with nearly 100 sponsors
- Phase 1B-4 GCP IND, IDE & PMA expertise
Access
- Direct Access to 150k+ charts in the Balboa Nephrology Medical Group EHR
⮕ 40k+ unique patients per year
⮕ 4k+ ESRD Patients
⮕ Vascular Access Center - Additional reach through Sharp & Scripps Healthcare
- Access to both Fresenius & DaVita Dialysis Centers
Infrastructure
- 10 Principal Investigators with an average of 11 years research experience
- 25+ full-time research staff; 12 Research Coordinators with an average tenure of 8 years
- 6 fully-equipped Research locations in San Diego & Imperial Counties
Principal Investigators
George Fadda, MD, FACP • La Mesa, CA
George Fadda, MD, FACP
- Research Experience: Founder of California Institute of renal Research (CIRR), 26 years research experience in basic and clinical research. Principal investigator participated in more than 95 phase 2-4 studies. CIRR Research Advisory Committee
- Publications: More than 50 Articles in Nephrology Journals
- Research Expertise: All aspects of Kidney disease: Acute renal failure and Chronic Kidney Disease Stages 2-5, ESRD, Type 2 DM, Hypertension, Hyperlipidemia, PCKD, FSGS, IgA Nephropathy, Hyperparathyroidism, Anemia, Iron, Proteinuria, etc.
- Training: MD – American University Beirut; Fellowship – University of Southern California; Assistant Professor of Medicine / Nephrology University of Southern California
Contact:
La Mesa
8851 Center Dr Ste 400 La Mesa, CA 91942
Phone: 619-461-3894
Fax: 619-463-0688
Jill Meyer, MD | Adam Horeish, MD • Chula Vista, CA
Jill Meyer, MD
- Research Experience: 20 years
- Research Expertise: drug device and diagnostics; phase II-IV: CKD 2-5, ESRD, HTN, DMII, hypercholesterolemia, IgA Nephropathy, FSGS, pruritis, anemia, hyperkalemia, vit hyperparathyroidism, infectious disease
- Training: MD – American University; residency – Hennepin County Medical Center; Fellowship – Emory University
Contact:
Chula Vista
340 4th Ave #5A, Chula Vista, CA 91910
Phone: 619-422-2687
Fax:
Adam Horeish, MD
- Research Experience: 4 years
- Research Expertise: drug, device, and diagnostics; phase II-IV: CKD 2-5, ESRD, HTN, DMII, hypercholesterolemia, IgA Nephropathy, FSGS, anemia, hyperkalemia, vit hyperparathyroidism, infectious disease
- Training: MD – Ross University School of Medicine; residency – Western Reserve Care System; Fellowship – University of Vermont
Contact:
Chula Vista
340 4th Ave #5A, Chula Vista, CA 91910
Phone: 619-422-2687
Fax:
Arman Faravardeh, MD, FACP, FASN, FAST | Kristian Brown, MD, PhD, FACP • Frost (Transplant & Vascular Access)
Arman Faravardeh, MD, FACP, FASN, FAST
- Research Experience: 10 years
- Publications, Lectures & Presentations: over 35
- Research Expertise: Kidney transplantation including delayed graft function, CMV disease, BK virus, COVID vaccine, APOL1, Belatacept trial, chronic antibody mediated rejection, donor derived cell free DNA assay
- Training: MD – Medical College of Wisconsin; Residency – Medical College of Wisconsin; Nephrology Fellowship – University of Minnesota; Transplant Nephrology Fellowship – UCLA
Contact:
SanDiego – Frost Street
8010 Frost St # 502, San Diego, CA 92123
Phone: 858-637-4600
Fax: 858-637-4601
Kristian Brown, MD, PhD, FACP
- Research Experience: 4 years
- Research Expertise: drug, device and diagnostics; phase II-IV: surgical transplant, vascular access, CMV, acute rejection, AKI, DGF, infectious disease
- Training: MD – University of Southern California; PhD in Biomedical Engineering – Wayne State University; residency – Detroit Medical center/Wayne State University; Abdominal Transplant/Hepatobiliary Fellowship – University of Southern California & Children’s Hospital of Los Angeles
Contact:
SanDiego – Frost Street
8010 Frost St # 502, San Diego, CA 92123
Phone: 858-637-4600
Fax: 858-637-4601
Ramin Berenji, MD, FACP, FASN • El Centro, CA
Ramin Berenji, MD, FACP, FASN
- Research Experience: 10 years; CIRR Research Advisory Committee
- Publications: 9 articles/abstracts
- Research Expertise: drug, device and diagnostics; phase II-IV: CKD 2-5, ESRD, HTN, cad, DMII, AKI, hypercholesterolemia, IgA Nephropathy, pruritis, FSGS, ADPKD, anemia, hyperkalemia, vit d def, hyperparathyroidism, infectious disease
- Training: MD – University of Hamburg school of medicine; Residency – Good Samaritan Hospital/John Hopkins; Fellowship – Stanford University
Contact:
El Centro
2205 Ross Ave #102, El Centro, CA 92243
Phone: 760-337-9575
Fax:
Osman Khawar, MD, MPH | Joseph Hebreo, MD • Escondido, CA
Osman Khawar, MD, MPH
- Research Experience: 10 years
- Publications: 15 Articles & 10 Posters
- Research Expertise: drug, device, diagnostics and investigator sponsored; phase Ia-IV: CKD 2-5, ESRD, HTN, vascular access, home HD, PD, CAD, pruritis, DMII, hypercholesterolemia, IgA Nephropathy, FSGS, anemia, hyperkalemia, hyperparathyroidism
- Training: MD – Glasgow university; Master’s of Public Health – John Hopkins School of Public health; Residency – St. Mary medical center, Long Beach; fellowship – Harbor-UCLA
Contact:
Escondido
631 E Grand Ave, Escondido, CA 92025
Phone: 760-294-3162
Fax: 858-366-4745
Joseph Hebreo, MD
- Research Experience: 4 years
- Publications: 2
- Research Expertise: drug, device, and diagnostics; phase Ia-IV: CKD 2-5, ESRD, HTN, vascular access, DMII, hypercholesterolemia, IgA Nephropathy, FSGS, anemia, hyperkalemia, hyperparathyroidism
- Training: MD – Albert Einstein College of Medicine; residency – Naval Medical Center, San Diego; Fellowship – Walter Reed Army Medical Center/National Naval Medical Center
Contact:
Escondido
631 E Grand Ave, Escondido, CA 92025
Phone: 760-294-3162
Fax: 858-366-4745
Dylan Steer, MD | Mark Boiskin, MD • Kearney Mesa, CA
Dylan Steer, MD
- Research Experience: 15 years
- Research Expertise: drug, device, diagnostics, and investigator sponsored; phase Ia-IV: CKD 2-5, ESRD, HTN, DMII, pruritis, hypercholesterolemia, anemia, hyperkalemia, hyperparathyroidism
- Training: MD – Duke University; Residency – Duke University; Fellowship – University of California San Diego.
Contact:
Kearny Mesa
7927 Ostrow St Ste. A, San Diego, CA 92111
Phone: 858-810-8180
Fax:
Mark Boiskin, MD
- Research Experience: 12 years
- Research Expertise: drug, device, diagnostics, and investigator sponsored; phase Ia-IV: CKD 2-5, ESRD, HTN, DMII, pruritis, anemia, hyperparathyroidism, dialysis access
- Training: MD – Stellenbosch medical school (south Africa); Residency – university of Alberta; Fellowship – University of California, San Diego
Contact:
Kearny Mesa
7927 Ostrow St Ste. A, San Diego, CA 92111
Phone: 858-810-8180
Fax:
California Institute of Renal Research – La Mesa
California Institute of Renal Research – La Jolla
California Institute of Renal Research – Kearny Mesa
California Institute of Renal Research – Frost Street
California Institute of Renal Research – Escondido
California Institute of Renal Research – El Centro
California Institute of Renal Research – Chula Vista
California Institute of Renal Research – El Centro
Phone: 760-337-9575
📍2205 Ross Ave #102
El Centro, CA 92243
Selection of Current Studies
| Multicenter, Open-Label, Adaptive Design Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RGL4326 Administered via Subcutaneous Injection to Patients with Autosomal Dominant Polycystic Kidney Disease | 1B |
| Phase 2 Multicenter, Randomized, Double-Blind, Placebo Controlled, Multiple Dosing Interval, 3-Period Study of the Safety, Tolerability and Effectiveness of adoptively Transferred Viralym-M Multivirus- 2 Specific T Cells in Kidney Transplant Recipients With Either High or Low Levels of BK Viremia | 2 |
| Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of AZD5718 in Participants with Proteinuric CKD | 2B |
| Study to Compare the Efficacy and Safety of Humacyte’s Human Acellular Vessel with that of an Autologous Arteriovenous Fistula in Subjects with ESRD | 3 |
| A Multicenter, randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients | 3 |
| Randomized, Double-Blind, Placebo-Controlled Study to assess the Efficacy and Safety of SNF472 When added to Background Care for the Treatment of Calciphylaxis | 3 |
| A Double-Blind Randomized Placebo-Controlled Parallel Design Multicenter Phase IIIb Study of the effect of Sodium Zirconium Cyclosilicate (SZC) on Serium Potassium and Serium Bicarbonate in Patients with Hyperkalemia and Metabolic Acidosis Associated with CKD | 3B |
| Industry Alliance Platform to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients | 4 |
| A Single-Arm Study to Evaluate the Effectiveness of EndoAVF in a Pre-Dialysis Population | 4 |